| Literature DB >> 27895930 |
Rahat Qureshi1, Sheikh Irfan Ahmed1, Amir Raza2, Ayesha Khurshid2, Uzma Chishti1.
Abstract
OBJECTIVE: Review of obstetric cases admitted to the intensive care unit.Entities:
Keywords: critical care; obstetrics; pregnancy
Year: 2016 PMID: 27895930 PMCID: PMC5117160 DOI: 10.1177/2054270416663569
Source DB: PubMed Journal: JRSM Open ISSN: 2054-2704
Outcomes of patients admitted to the intensive care unit with regards to their gravidity, pregnancy status and source of admission.
| Variables | Total | Survived | Expired | Odds ratio [95% confidence interval] |
|---|---|---|---|---|
| Gravidity | ||||
| Primigravida | 67 | 54 (80.6%) | 13 (19.4%) | 0.81 [0.39–0.169] |
| Multigravida | 127 | 98 (77.2%) | 29 (22.8%) | |
| Pregnancy status | ||||
| Antenatal | 72 | 57 (79.2%) | 16 (22.2%) | 1.03 [0.51–2.07] |
| Postnatal | 121 | 95 (78.5%) | 26 (21.5%) | |
| Source of admission | ||||
| Emergency department | 74 | 52 (70.3%) | 22 (29.7%) | 2.11 [1.06–4.23] |
| Obstetrics and gynecology department | 120 | 100 (83.3%) | 20 (16.7%) |
Results are presented as n (%).
Demographics and laboratory findings (n: 194).
| Variables | Median(IQR) |
|---|---|
| Age (years) | 34.5 (29–37) |
| Intensive care unit stay (days) | 27 (18–32) |
| Haemoglobin (11.1–14.5 g/dL) | 9 (7–10) |
| WBC (4.5–10.0 × 109/L | 14 (9.6–16.4) |
| Platelets (150–400 × 109 L | 220 (148–259) |
| Creatinine (0.6 to 1.1 mg/dL) | 4.3 (3–5) |
| INR | 10.4 (7.2–12.2) |
IQR: interquartile range; INR: international normalised ratio.
Comparison of co-morbidities in survived and expired patients (n: 194).
| Obstetric Complications | Total | Survived | Expired | Odds ratio [95% confidence interval] |
|---|---|---|---|---|
| CVS | 48 (24.7%) | 40 (26.3%) | 8 (19%) | 0.66 [0.28–1.54] |
| A. Peripartum cardiomyopathy | 14 (7.2%) | 10 (6.6%) | 4 (9.5%) | |
| B. Hypertensive disease of pregnancy | 34 (17.5%) | 30 (19.7%) | 4 (9.5%) | |
| I. Pre-eclampsia | 27 (13.9%) | 24 (15.8%) | 3 (7.1%) | |
| II. Gestational HTN | 3 (1.5%) | 3 (2%) | – | |
| III. Superimposed pre-eclampsia | 4 (2.1%) | 3 (2%) | 1 (2.4%) | |
| Respiratory | 25 (12.9%) | 20 (13.2%) | 5 (11.9%) | 0.89 [0.31–2.54] |
| A. Amniotic fluid embolus | 1 (0.5%) | 0 (0%) | 1 (2.4%) | |
| B. Pulmonary edema | 15 (7.7%) | 12 (7.9%) | 3 (7.1%) | |
| C. ARDS | 4 (2.1%) | 3 (2%) | 1 (2.4%) | |
| Others | 5 (2.6%) | 5 (3.3%) | – | |
| GI | 15 (7.7%) | 7 (4.6%) | 8 (19%) | 4.87 [1.65–14.36] |
| A. HELLP | 4 (2.1%) | 3 (2%) | 1 (2.4%) | |
| B. Acute fatty liver | 2 (1%) | 2 (1.3%) | – | |
| C. Hepatitis E | 9 (4.6%) | 2 (1.3%) | 7 (16.7%) | |
| Renal | 15 (7.7%) | 12 (7.9%) | 3 (7.2%) | 0.89 [0.24–3.34] |
| Proteinuria | 7 (3.6%) | 6 (3.9%) | 1 (2.4%) | |
| Others | 8 (4.1%) | 6 (3.9%) | 2 (4.8%) | |
| Endocrine | 7 (3.6%) | 5 (3.3%) | 2 (4.8%) | 1.47 [0.27–7.86] |
| Haematological | 55 (28.4%) | 39 (25.7%) | 16 (38.1%) | 1.78 [0.86–3.66] |
| Sepsis | 39 (20.1%) | 31 (20.4%) | 8 (19%) | 0.92 [0.82–2.18] |
| A. Pelvic sepsis | 36 (18.6%) | 28 (18.4%) | 8 (19%) | |
| B. Mastitis | 3 (1.5%) | 3 (2%) | – |
Data are expressed as n (%).
CVS: cardiovascular system; GI: gastrointestinal; GDM: gestational diabetes mellitus; ARDS: acute respiratory distress syndrome; HTN: Hypertension; HELLP: haemolysis, elevated liver enzyme levels, low platelet levels.